ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases

ClinicalTrials.gov ID: NCT04523207

Public ClinicalTrials.gov record NCT04523207. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 3:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Open-label, Single-arm Phase 2 Study of the Adjuvant Treatment of Apalutamide and Androgen Deprivation Therapy (ADT) in Treatment-naïve Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases

Study identification

NCT ID
NCT04523207
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
108 participants

Conditions and interventions

Interventions

  • ADT Drug
  • Apalutamide Drug
  • Relugolix Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 18, 2020
Primary completion
Oct 22, 2023
Completion
Oct 24, 2023
Last update posted
Apr 20, 2026

2020 – 2023

United States locations

U.S. sites
32
U.S. states
23
U.S. cities
31
Facility City State ZIP Site status
Arizona Urology Specialists 1 Tucson Arizona 85704
Arizona Urology Specialists Tucson Arizona 85741
Arkansas Urology Little Rock Arkansas 72211
Skyline Urology Sherman Oaks California 91411
Genesis Research Torrance California 90505
The Urology Center of Colorado Denver Colorado 80211
Foothills Urology - Golden Off Lakewood Colorado 80228
Urological Research Network Hialeah Florida 33016
Idaho Urologic Institute Meridian Idaho 83642
First Urology, PSC Jeffersonville Indiana 47130
The Iowa Clinic West Des Moines Iowa 50266
Wichita Urology Group Wichita Kansas 67226
Ochsner LSU Health Shreveport - Regional Urology Shreveport Louisiana 71106
Michigan Institute of Urology, PC Troy Michigan 48084
Adult Pediatric Urology & Urogynecology, P.C Omaha Nebraska 68114
New Jersey Urology LLC Voorhees Township New Jersey 08043
Great Lakes Physician PC d/b/a Western New York Urology Associates Cheektowaga New York 14225
Associated Medical Professionals Syracuse New York 13210
Associated Urologists of North Carolina Raleigh North Carolina 27612
The Urology Group Cincinnati Ohio 45212
Oregon Urology Institute Springfield Oregon 97477
MidLantic Urology Bala-Cynwyd Pennsylvania 19004
Lancaster Urology Lancaster Pennsylvania 17604
Carolina Urologic Research Center Myrtle Beach South Carolina 29572
Lexington Urology West Columbia South Carolina 20169
Urology Associates Nashville Tennessee 37209
Urology Austin Austin Texas 78745
Houston Metro Urology Houston Texas 77027
Urology San Antonio Research San Antonio Texas 78229
Virginia Urology Richmond Virginia 23235
Urology Of Virginia, Pllc Virginia Beach Virginia 23462
Spokane Urology Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04523207, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04523207 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →